BIPM (Bureau International des Poids et Measures). 2006. The International System of Units (SI). Sevres: BIPM. Accessed 16 Apr 2015.

Cano, S.J., and J.C. Hobart. 2011. The problem with health measurement. Patient Preference and Adherence 5: 279-290.

Chauhan, C. 2007. Denouement: A Patient-Reported Observation. Value in Health 10: S146-S147.

Critical Path Institute. 2015. Accessed 7 Apr 2015.

DeMuro, C., M. Clark, L. Doward, E. Evans, M. Mordin, and A. Gnanasakthy. 2013. Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006-2010). Value in Health 16(8): 1150-1155.

Douglas, H. 2009. Science, Policy, and the Value-Free Ideal. Pittsburgh: University of Pittsburgh Press.

Fayers, P., and D. Machin. 2007. Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes, 2nd ed. Chichester: Wiley.

Food and Drug Administration. 2007. Drug Development Tools Qualification Programs > Clinical Outcome Assessment Qualification Program. DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm284077. htm. Accessed 7 Apr 2015.

Hobart, J.C., S.J. Cano, J.P. Zajicek, and A.J. Thompson. 2007. Rating Scales as Outcome Measures for Clinical Trials in Neurology: Problems, Solutions, and Recommendations. Lancet Neurology 6(12): 1094-1105.

Hunt, S.M. 1997. The Problem of Quality of Life. Quality of Life Research 6(3): 205-212.

Jaeschke, R., J. Singer, and G.H. Guyatt. 1989. Measurement of Health Status. Ascertaining the Minimal Clinically Important Difference. Contemporary Clinical Trials 10(4): 407-415.

McClimans, L. 2010a. Towards Self-Determination in Quality of Life Research: A Dialogic Approach. Medicine, Health Care, and Philosophy 13(1): 67-76.

--. 2010b. A Theoretical Framework for Patient-Reported Outcome Measures. Theoretical

Medicine and Bioethics 31(3): 225-240.

--. 2011. Interpretability, Validity, and the Minimum Important Difference. Theoretical

Medicine and Bioethics 32(6): 389-401.

--. 2017. Measurement in Medicine and Beyond: Quality of Life, Blood Pressure and Time.

In Reasoning in Measurement, ed. N. MoBner and A. Nordmann. London: Routledge.

McClimans, L., and J.P. Browne. 2012. Quality of Life Is a Process Not an Outcome. Theoretical Medicine and Bioethics 33(4): 279-292.

Schwartz, C.E., and M.A. Sprangers. 1999. Methodological Approaches for Assessing Response Shift in Longitudinal Health-Related Quality-of-Life Research. Social Science & Medicine 48(11): 1531-1548.

Sismondo, S. 2007. Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry? PLoS Medicine 4(9): e286.

Sismondo, S., and M. Doucet. 2010. Publication Ethics and the Ghost Management of Medical Publication. Bioethics 24(6): 273-283.

Sismondo, S., and S.H. Nicholson. 2009. Publication Planning 101. Journal of Pharmacy & Pharmaceutical Sciences 12(3): 273-279.

Stenner, A.J., and M. Smith. 1982. Testing Construct Theories. Perceptual and Motor Skills 55(2): 415-426.

Streiner, D.L., and G.R. Norman. 2008. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford: Oxford University Press.

Tal, E. 2011. How Accurate Is the Standard Second? Philosophy in Science 78(5): 1082-1096.

Taminiau-Bloem, E.F., F.J. Van Zuuren, M. Visser, C. Tishelman, C.E. Schwartz, M.A. Koeneman, C. Koning, and M. Sprangers. 2011. Opening the Black Box of Cancer Patients’ Quality-of- Life Change Assessments: A Think-Aloud Study Examining the Cognitive Processes Underlying Responses to Transition Items. Psychology & Health 26(11): 1414-1428.

Terwee, C.B., F.W. Dekker, W.M. Wiersinga, M.F. Prummel, and P. Bossuyt. 2003. On Assessing Responsiveness of Health-Related Quality of Life Instruments: Guidelines for Instrument Evaluation. Quality of Life Research 12(4): 349-362.

Wyrwich, K.W., and V.M. Tardino. 2006. Understanding Global Transition Assessments. Quality of Life Research 15(6): 995-1004.

< Prev   CONTENTS   Source   Next >